Background and aims: Several small studies reported high risk of progression to high grade dysplasia (HGD) and esophageal adenocarcinoma (EAC) in Barrett’s esophagus (BE) patients who undergo solid organ transplantation (SOT)…
Esophageal adenocarcinoma (EAC) has been associated with poor survival, with an estimated median survival of 15 months. Neoadjuvant chemoradiation (NCRT) followed by esophagectomy is considered the standard of care for locally advanced EAC…
BACKGROUND: Sleeve gastrectomy (SG) is one of the most commonly performed bariatric procedures worldwide. Gastroesophageal reflux disease (GERD) is a major concern in patients undergoing SG and is a risk factor for Barrett's esophagus (BE)…